| Description | Diatrizoate meglumine (Renocal) is the meglumine salt of diatrizoate, it is an organic, iodinated, radiopaque X-ray contrast medium used in diagnostic radiography. |
| Synonyms | Reno, Renografin, Renovist, 泛影葡胺, Hypaque, Renocal, Sinografin |
| molecular weight | 809.13 |
| Molecular formula | C18H26I3N3O9 |
| CAS | 131-49-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 60 mg/ml (74.15 mM) |
| References | 1. Peterson CM, Lin M, Pilgram T, Heiken JP. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. J Comput Assist Tomogr. 2011 Mar-Apr;35(2):202-5. 2. Hayman LA, Pagani JJ, Serur JR, Hinck VC. Impermeability of the blood-brain barrier to intravenous high-iodine-dose meglumine diatrizoate in the normal dog. AJNR Am J Neuroradiol. 1984 Jul-Aug;5(4):409-11. PubMed PMID: 6205572. 3. Shea JJ, Emmett JR, Harell M. Evaluation of diatrizoate meglumine (Hypaque) in treatment of sudden hearing loss. Laryngoscope. 1977 Nov;87(11):1809-14. PubMed PMID: 916773. 4. Jacobson ED, Eldon C, Fondacaro JD. Effects of a rapid injection into the canine superior mesenteric artery of diatrizoate meglumine and diatrizoate sodium (Renografin-76). Cardiovasc Intervent Radiol. 1980;3(3):159-62. PubMed PMID: 7407811. |